Point72 Asset Management
CNTB

Point72 Asset Management’s Connect Biopharma Holdings CNTB Stock Holding History

Point72 Asset Management’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.8K Buy
19,766
+3,263
+20% +$8.51K ﹤0.01% 3657
2025
Q4 		$46.5K Buy
+16,503
New +$35.2K ﹤0.01% 3793

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Point72 Asset Management's CNTB Position: Q1 2026 in Review

Point72 Asset Management increased its Connect Biopharma Holdings (CNTB) stake by 20% in Q1 2026, buying an estimated $8.51K and bringing the position to 19,766 shares worth $51.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

Point72 Asset Management first reported a position in CNTB in Q4 2025 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Point72 Asset Management held 19,766 shares of Connect Biopharma Holdings worth $51.8K as of Q1 2026.
  • Point72 Asset Management bought 3,263 Connect Biopharma Holdings shares in Q1 2026, an estimated $8.51K.
  • Connect Biopharma Holdings made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3657 holding.
  • Point72 Asset Management first reported a position in Connect Biopharma Holdings in Q4 2025 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.